SynthesisFrontiers in pharmacology2024

Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis.

Liyuan Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.